HOOKIPA Pharma Inc.
OTC: HOOK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Malte Peters
- Employees
- 82
- Headquarters
- New York, United States
- IPO year
- 2019
- Market cap
- $14.4M
- Website
- https://www.hookipapharma.com
Loading HOOK…
Loading profile data…Frequently asked questions about HOOK
What does HOOKIPA Pharma Inc. (HOOK) do?
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunetherapeutics targeting infectious diseases based on its proprietary arenavirus platform. The company’s immuno-oncology pipeline includes HB-700, a novel next-generation multi-KRAS mutant-targeting investigational immunotherapy for the treatment of KRAS mutated cancer...
Where does HOOK trade?
HOOKIPA Pharma Inc. (HOOK) trades on the Other OTC.
What sector is HOOK in?
HOOKIPA Pharma Inc. (HOOK) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of HOOKIPA Pharma Inc.?
Malte Peters is the chief executive officer of HOOKIPA Pharma Inc. (HOOK).
Where is HOOKIPA Pharma Inc. headquartered?
HOOKIPA Pharma Inc. is headquartered in United States.
Does HOOK pay a dividend?
HOOKIPA Pharma Inc. (HOOK) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did HOOK go public?
HOOKIPA Pharma Inc. (HOOK) completed its initial public offering in 2019.